Publication: 4693

Clinical and molecular characterization of AXL in colorectal cancer, CALGB (Alliance)/SWOG 80405 and real-world data.
      Google Scholar   
Citation:
J Immunother Cancer vol 13 (12)
Year:
2025
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
Alliance-data-source,-external-user
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
4290  
Children:
None
Program:
TRP
Primary Committee:
Correl Sci NOS
Sec. Committees:
   
Pharmas:
Bristol-Myers Squibb, Genentech, Pfizer  
Grants:
U10CA180821, U10CA180882; UG1CA233331, P30CA014089, UG1CA180830; UG1CA180830, U10CA180888 (SWOG);  
Corr. Author:
 
Authors:
                                               
Networks:
CA011, CA824, CAPITAL, LAPS-OH007, MN022, SCOR   
Study
Alliance-A152001
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-80405
Phases:
N/A, 3
Keywords: